Xiaoyu Fu

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Progress of Non-Aqueous Liquid Electrolytes for High-Voltage Sodium-Ion Batteries.

Progress of Non-Aqueous Liquid Electrolytes for High-Voltage Sodium-Ion Batteries.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: December 06, 2025

Effects of Gut Microbiome and Metabolic Pathways on Obesity: A Two-Sample Mendelian Randomization and Case-Control Study.

Effects of Gut Microbiome and Metabolic Pathways on Obesity: A Two-Sample Mendelian Randomization and Case-Control Study.

Journal: Iranian journal of biotechnology
Published: November 14, 2025

Eleutheroside B ameliorates AD-like pathological features in Caenorhabditis elegans by inducing autophagy and combating oxidative stress.

Eleutheroside B ameliorates AD-like pathological features in Caenorhabditis elegans by inducing autophagy and combating oxidative stress.

Journal: Free radical biology & medicine
Published: October 25, 2025

Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study.

Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study.

Journal: Drug design, development and therapy
Published: October 16, 2025

Insights into the treatment of infliximab and vedolizumab in positive PR3-ANCA patients with moderately to severely active ulcerative colitis: multicenter real-world evidence.

Insights into the treatment of infliximab and vedolizumab in positive PR3-ANCA patients with moderately to severely active ulcerative colitis: multicenter real-world evidence.

Journal: BMC gastroenterology
Published: July 01, 2025

Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

Journal: BMC gastroenterology
Published: June 04, 2025

Rituximab in PR3-ANCA positive patients with moderately to severely active ulcerative colitis: a multicenter real-world pilot study.

Rituximab in PR3-ANCA positive patients with moderately to severely active ulcerative colitis: a multicenter real-world pilot study.

Journal: Frontiers in pharmacology
Published: May 01, 2025

Baicalein from Scutellaria baicalensis mitigates oxidative stress through the IIS pathway in a C. elegans model of ulcerative colitis.

Baicalein from Scutellaria baicalensis mitigates oxidative stress through the IIS pathway in a C. elegans model of ulcerative colitis.

Journal: Frontiers in pharmacology
Published: March 12, 2025

Estrogen receptor β alleviates colitis in intestinal epithelial cells and activates HIF-1a and ATG-9a-mediated autophagy.

Estrogen receptor β alleviates colitis in intestinal epithelial cells and activates HIF-1a and ATG-9a-mediated autophagy.

Journal: Experimental cell research
Published: October 22, 2024

Estrogen Receptor β Alleviates Colitis by Inhibiting Ferroptosis in Intestinal Epithelial Cells.

Estrogen Receptor β Alleviates Colitis by Inhibiting Ferroptosis in Intestinal Epithelial Cells.

Journal: Journal of inflammation research
Published: September 22, 2024

Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4.

Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4.

Journal: Journal of advanced research
Published: February 04, 2024

Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis.

Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis.

Journal: International journal of molecular sciences
Published: August 08, 2023
Showing 1-12 of 13

Last Updated: 09/26/2026